Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 16, Art. 16 (pp. 187-202)    |    2015       

»

Development of experimental models of alcoholic hepatitis of varying severity

Petrov A.N., Shevchuk M.K., Georgianova E.K., Sivak K.V., Stosman K.I.

Federal State Institution of Science "Institute of Toxicology, Federal Medical-Biological Agency"

Brief summary

We represent two experimental models of alcoholic hepatitis based on intragastric administration of progressively increasing doses of rectified alcohol in intact animals or animals with a pre-formed liver disease caused by toxic effects of carbon tetrachloride. In the first case within 2.5 months we obtained alcoholic hepatitis of mild to medium severity depending on the duration of administration and dose; in the second case abnormality develops within 8 days. The latter model can be used for express-screening of hepatoprotective preparations.


Key words

Alcoholic hepatitis, experimental models, biomarkers, hepatoprotective preparations, cytolysis, cholestasis.

Reference list

1. Syhareva G.V. Alkogolnaya bolezn pecheni // Consilium medicum. Gastroenterologiya. – 2003. – T. 5, № 3. – S. 26-27.


2. Myhin A.S. Alkogolnaya bolezn pecheni: avtoref. dis. d-ra med. nayk. – M., 1980.– 32 s.


3. Ivannikov I.O., Sutkin V.E. Obshaya gepatologiya. – M.: Medpraktika, 2003. – 160 s.


4. Loginov A.S., Blok U.E., Djalalov K.D. Alkogol i pechen – M.: Visshaya shkola, 1987. – 94 s.


5. Nikitin I.G. Immynnie mehanizmi progressirovaniya alkogolnoi bolezni pecheni // Gepatologicheskii forym. – 2005. – № 4. – S. 8-11.


6. Byrov U.V., Jykov V.N. Biologicheskie modeli hronicheskogo alkogolizma // Toksikologiya VINITI. – 1984. – T.13. – S. 57-92.


7. Tokeyama Y., Kamimura S. et al. Role of Kupfer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo // Alcohol Clin. Exp. Res. – 1996. – V.20 (Suppl.). – P. 335-339.


8. Nawasurit P., Ward T.H., Dodd N.J.F. Ethanol–induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants // Carcinigenesis. – 2000. – V. 21. – P. 93-99.


9. Corsetti G., Stacchiotti A., Tedesco L., D'Antona G., Pasini E., Dioguardi F.S., Nisoli E., Rezzani R. Essential amino acid supplementation decreases liver damage induced by chronic ethanol consumption in rats // Int J Immunopathol Pharmacol. – 2011. – V. 24(3). – R. 611-619.


10. Habib-ur-Rehman M., Mahmood T., Salim T., Afzal N., Ali N., Iqbal J., Tahir M., Khan A. Affect of silymarin on serum levels of ALT and GGT in ethanol induced hepatotoxicity in albino rats // J. Ayib. Med.Col. Abbottabad. – 2009. – V. 21. – P. 73-75.


11. Lieber C.S., De Carli L.M. Quantitive relationship between the amount of dietery fat and the alcoholic fatty liver // Amer. J. Clin. Nutr. – 1970. – V. 23. – P. 474-478.


12. Popper H., Lieber L.S. Histogenesis of alcoholic fibrosisand cirrosis in the baboon // Amer. J. Pathol. – 1980. – V.98. – P. 695-716.


13. Grigorev P.Ya., Yakovenko E.Ya. Diagnostika i lechenie hronicheskogo gepatita i cirroza pecheni // Sovetskaya medicina. – 1985. – № 12. – S. 61-67.


14. Kostukevich O.I. Alkogolnoe porajenie pecheni: socialnoe zvychanie, klinicheskie posledstviya i aspekti patogeneticheskoi terapii // Bolezni organov pishevareniya. – 2007. – №2. – S. 62-67.


15. Degtyareva A.V., Myhina U.G., Volodin N.N. Proekt protokola differencialnoi diagnostiki i lecheniya sindroma holestaza y novorojdennih detei. – M.: Izd-vo MMA, 2010. – 14 s.


16. Alatalo P., Koivisto H., Puukka K., Hietala J., Anttila P., Bloigu R., Niemelä O. Biomarcers of liver status in Heavy drinkers, moderat drinkers and abstainers Alcohol // Alcohol. – 2009. – V. 44(2). – P. 199-203.


17. Puukka K., Hietala J., Koivisto H., Anttila P., Bloigu R., Niemelä O. Addictive effects of moderate drinking and obesity jn serum gamma-glutamiyl tansferase activity // Am J Clin Nutr. – 2006. – V. 83(6). – P. 1351-1354.


18. Niemelä O. Biomarker in alcogolism // Clin Chim Acta. – 2007. – V. 377(1-2). P. 39-49.


19. Degtyareva A.V., Myhina U.G., Volodin N.N. Proekt protokola differencialnoi diagnostiki i lecheniya sindroma holestaza y novorojdennih detei. – M.: Izd-vo MMA, 2010. – 14 s.


20. Sivak K.V. Biomarkeri alkogolnogo porajeniya pecheni i podjelydochnoi jelezi // Chelovek i alkogol (alkogolnie bolezni): materiali 3-go mejdisciplinarnogo rossiiskogo kongressa 23-24 aprelya 2009 g. – SPb., 2009. – S. 68.


21. Bylgakova V.S., Visokogorskii V.E., Pritikina T.V., Titov S.S. Naryshenie obmena yglevodsoderjashih soedinenii pri alkogolnoi intoksikacii // Narkologiya. – 2008. – № 5. – S. 50-53.


22. Albano E., Vidali M. Immune mechanism in alcoholic liver disease // Genes Nutr. –2010. – V. 5(2). – P. 141-147.


23. Alekseenko S.A., Shypak A.U., Lebedko O.A., Pychkov U.A. Ostrii toksicheskii gepatit, razvivshiisya vsledstvie ypotrebleniya spirtsoderjashih dezinfektantov. – Habarovsk, 2010. – 157 s.


24. Alyatin U.S., Tyryanov M.H. Alkogolnoe porajenie pecheni: differencialnaya diagnostika s virysnimi gepatitami // Epidem. i infekc. bolezni. – 2003. – №1. – S. 58.


25. Ketlinskii S.A., Kalinina N.M. Immynologiya dlya vracha. – SPb.: Gippokrat, 1998. – 156 s.


26. Menshikov V.V. Laboratornie metodi issledovaniya v klinike. Spravochnik. –M., 1987. – 365 s.


27. Metodicheskie ykazaniya po izycheniu gepatozashitnoi aktivnosti farmakologicheskih veshestv (V sb. Rykovodstvo po eksperimentalnomy (doklinicheskomy) izycheniu novih farmakologicheskih veshestv). – M., 2000. – C. 228.


28. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor // Ann. Clin. Biochem. – 1969.– V.6. – P. 24.


29. Macut D. et al. Oxidised lowdensity lipoprotein concentration – early marker of an altered lipid metabolism in young women with PCOS // Eur. J. Endocrinol. – 2006. – V.155, № 1. – P. 131-136.


30. Winn-Deen T.S. Development of a direct assay for alpha-amylase // Clin.Chem. – 1988. – V. 34, №10. – P. 2005-2008.


31. Ridnour L.A., Sim J.E., Hayward M.A., Wink D.A., Martin S.M., Buettner G.R., Spitz D.R. A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite, and nitrate in cell culture media // Anal Biochem. – 2000. – V.281 – P. 223-229.


32. Mehtiev S.P., Kravchyk U.A., Karpov S.V., Shirokih A.V. Patogenez i podhodi k terapii pri ostrom alkogolnom gepatite. Materiali 3-go mejdisciplinarnogo rossiiskogo kongressa «Chelovek i alkogol (alkogolnie bolezni)». – SPb, 2009. – S. 12-17.


33. Nchez Perez M.J., Lez-Reimers E.G. et al. Lipid peroxidation and serum cytokines in acute alcoholic hepatitis // Alcohol and Alcoholism. – 2006. – V. 41. – P. 593-597.


34. Lyjnikov E.A., Goldfarb U.S., Marypov A.M. Endotoksikoz pri ostrih ekzogennih otravleniyah. – M.: «Binom», 2008. – 200 s.


35. Maevskaya M.V., Byeverov A.O. Citokini v patogeneze alkogolnogo gepatita i vozmojnosti terapii // Rossiiskii jyrnal gastroenterologii, gepatologii i koloproktologii. – 2009. – №2. – S. 14-19.


36. Ilnickii A.N., Jernakova N.I., Postnikova L.I., Borisov O.A., Pozdnyakova N.M. Molekylyarnie mehanizmi neiroimmynoendokrinnih effektov alkogolya i somaticheskaya patologiya // Naychnie vedomosti Seriya Medicina. Farmaciya. – 2011. – № 4 (99). Vipysk 13. – S. 5-12.

Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций

(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции